Trials / Completed
CompletedNCT01877122
Comparative Study of Safety and Efficacy of Heavyweight and Partially Absorbable Mesh in Inguinal Hernia Repair
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Samyang Biopharmaceuticals Corporation · Industry
- Sex
- Male
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Proflex® Mesh (partially absorbable mesh, Korea) and Marlex® Mesh (heavyweight mesh) will be used for inguinal hernia repair to compare the safety and efficacy (pain score, quality of life)of two devices at 3 months follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Proflex® Mesh Mesh implantation | Implantation of mesh in the incision of inguinal area |
| DEVICE | Marlex® Mesh Implant |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-06-13
- Last updated
- 2015-06-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01877122. Inclusion in this directory is not an endorsement.